https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-23 / Thorac Cancer 2018 Nov;9(11):1437-1452
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-23 / Thorac Cancer 2018 Nov;9(11):1437-14522018-09-23 00:00:002019-02-15 08:45:47Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-18 / Oncol Lett 2018 Nov;16(5):6742-6748
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-18 / Oncol Lett 2018 Nov;16(5):6742-67482018-09-18 00:00:002019-03-27 10:59:42Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-17 / Int J Mol Sci 2018 Sep;19(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-17 / Int J Mol Sci 2018 Sep;19(9)2018-09-17 00:00:002019-02-15 09:18:17Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-13 / 2018 11;103:98-107
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-13 / 2018 11;103:98-1072018-09-13 00:00:002020-10-05 10:21:06Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-1638
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-16382018-09-11 00:00:002018-09-11 00:00:00Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-07 / Front Immunol 2018;9:2034
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-07 / Front Immunol 2018;9:20342018-09-07 00:00:002020-09-07 08:00:31Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-07 / Integr Cancer Ther 2018 12;17(4):1297-1303
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-07 / Integr Cancer Ther 2018 12;17(4):1297-13032018-09-07 00:00:002019-03-27 11:12:22Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-06 / 2018 Sep;7(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-06 / 2018 Sep;7(9)2018-09-06 00:00:002018-09-06 00:00:00Role of Vitamin A in the Immune System
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-01 / 2018 Sep;10(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-01 / 2018 Sep;10(9)2018-09-01 00:00:002018-09-01 00:00:00Selenium, Selenoproteins, and Immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-08-29 / CNS Oncol 2018 07;7(3):CNS22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-08-29 / CNS Oncol 2018 07;7(3):CNS222018-08-29 00:00:002019-02-15 09:00:10Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte counts
